ARTICLE | Clinical News
Pralatrexate regulatory update
March 1, 2010 8:00 AM UTC
The COMP of the European Medicines Agency (EMA) issued a positive opinion to grant Orphan Drug designation to Allos' pralatrexate to treat cutaneous T cell lymphoma (CTCL). The small molecule dihydro...